Tuesday 2 December 2014

Bayer to seek approval for new hemophilia drug by year-end

The logo of Bayer AG is pictured at the Bayer Healthcare subgroup production plant in Wuppertal FRANKFURT (Reuters) - German drugmaker Bayer AG will file for regulatory approval of its experimental hemophilia drug Bay 81-8973 by the end of the year, it said on Tuesday. (Reporting by Ludwig Burger; Editing by Maria Sheahan)




via Health News Headlines - Yahoo News Read More Here..

No comments:

Post a Comment